Employee-Paid

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, including Pfizer, Novo Nordisk and GlaxoSmithKline.

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief Act 2025 at the last minute.

The new withdrawal is the second preventive benefits-related withdrawal announced in less than a month.

Margin expansion at Express Scripts, Caremark and Optum Rx increased by $336 million between 2017 and 2021, officials say.

The ERISA Industry Committee battle against crazy quilt benefits rules now involves skirmishes in Tennessee and Maryland.